United Kingdom· GB-APID-35171711000001108

Midotense 2.5mg tablets

A midodrine product containing midodrine, registered in United Kingdom by Transdermal Ltd. The same ATC class is registered in 15 of our 19 countries.

ATC C01CA17

Checked against NHS dm+d (United Kingdom) on September 13, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about midodrineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Midodrine is registered in 15 of 19 countries.

Countries holding a registration under ATC C01CA17 (midodrine), each read from that country’s own register.

This record: United Kingdom, from NHS dm+d (United Kingdom)
8 of them publish a price we can compare per daily dose

Search midodrine products by name

Midodrine · ATC C01CA17

15 / 19 countries

Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of midodrine costs, country by country.

Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.67 in United States to $9.42 in Switzerland — a ×14 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Midodrine · price per daily dose (30 mg)

USD · FX 28 Sept 2026

CH Switzerland$9.42
FR France$2.73
US United States$0.67 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)

Active substance: Midodrine
Manufacturer: Transdermal Ltd
Country: United Kingdom (GB)
ATC code: C01CA17
ATC class: Midodrine
Defined daily dose: 30 mg, O
Reimbursed: Not published by this register
Source register: NHS dm+d (United Kingdom)
Last checked: September 13, 2026

Packs & prices · 1

gtin
5060052450197

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

115 interactions on record for midodrine.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check midodrine against other medicines How interaction checks work

Midodrine · interactions on record

115 records

2 severe
84 moderate
3 minor
26 info

Most severe, free to view

Iobenguane (123I)V09IX01severe
Iobenguane (131I)V09IX02severe
EpinephrineA01AD01moderate
TrospiumA03AB20moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Midodrine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All midodrine products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

Austria · Gutron
Bulgaria · Гутрон
Cyprus · Midodrine Tillomed
Czechia · Gutron
Germany · Gutron
Denmark · Augermid, Hypotron
Spain · Gutron
Finland · Hypotron, Midodrine Tillomed
France · Gutron, Midodrine Arrow
Greece · Midodrine Tillomed
Hungary · Gutron
Ireland · Midodrine Hydrochloride Aspire, Midodrine Tillomed
Iceland · Hypotron, Midodrin Evolan
Italy · Gutron
Netherlands · Gutron, Midodrine Hcl Brancaster
Norway · Augermid, Hypotron
Poland · Gutron
Portugal · Gutron
Romania · Gutron
Sweden · Augermid, Hypotron

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e3cca78b-fe1c-4dd4-b0d4-c63a5dab435a
GET /v1/drugs/e3cca78b-fe1c-4dd4-b0d4-c63a5dab435a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "35171711000001108",
  "desc": "Midotense 2.5mg tablets (Transdermal Ltd)",
  "form": "Oral tablet",
  "vpid": "42213811000001106",
  "source": "dmd",
  "vtm_id": "776787004",
  "strength": "2.5 mg",
  "substance": "Midodrine",
  "ingredient": "Midodrine hydrochloride",
  "supplier_code": "4516711000001108"
}

API reference MCP server Plans

See everything about midodrine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console